Lighting the way
with our companion
Happiness lies in time with your family and loved ones
we hope to be a beacon lightening the way
About MEDIIMG
Leading company for overcoming cerebrovascular disease
MEDIIMG, a company specializing in hemodynamics and AI,
To overcome cerebrovascular diseases such as cerebral aneurysm
We are devoting ourselves to the development and research of technology.
MISSION
"Lighting the way with our companion"
We pursue revolutionary innovation in cerebrovascularhealth with new biomarker
FUTURE
We design a healthy future with our new biomarker for cerebrovascular network.
Mediimage aims to open a new era of prevention and diagnosis of cerebrovascular disease
with our new method to digitize information on cerebral arteries.
We will light the way with our companions.
Our History
2024
01 Seed investment secured from Bluepoint Partners
06 Selected for the TIPS program
2023
01 VINT regulatory approved by MFDS
08 New Medical Technology Application Eligibility approved by NECA
2022
10 Certified for compliance to GMP of Medical Devices by KCL
09 Usability test cleared by Gachon Medical Device Convergence Center
2021
11 R&D funds guaranteed by Korea Technology Finance Corporation(KIBO)
07 R&D Department accredited by MSIT
2018
01 MEDIIMG was founded
MEDIIMG Collaborates with various R&D Partners
